Daniel D. Shapiro

566 total citations
31 papers, 333 citations indexed

About

Daniel D. Shapiro is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Daniel D. Shapiro has authored 31 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Daniel D. Shapiro's work include Renal cell carcinoma treatment (20 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Renal and related cancers (7 papers). Daniel D. Shapiro is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Renal and related cancers (7 papers). Daniel D. Shapiro collaborates with scholars based in United States. Daniel D. Shapiro's co-authors include E. Jason Abel, Pavlos Msaouel, Meghan G. Lubner, José A. Karam, Rodney A. Welch, David C. Goodspeed, Kevin J. Schwartz, John W. Davis, Tharakeswara Bathala and Daniel Stevens and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Urology.

In The Last Decade

Daniel D. Shapiro

27 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel D. Shapiro United States 13 228 118 82 51 49 31 333
C. Martín de Vidales Spain 13 398 1.7× 65 0.6× 187 2.3× 82 1.6× 48 1.0× 38 633
Itay Sternberg United States 13 149 0.7× 96 0.8× 241 2.9× 60 1.2× 24 0.5× 27 396
Yue Du China 7 93 0.4× 58 0.5× 26 0.3× 24 0.5× 32 0.7× 44 263
Roberto Contieri Italy 11 117 0.5× 87 0.7× 231 2.8× 43 0.8× 24 0.5× 63 361
Ikko Tomisaki Japan 11 114 0.5× 33 0.3× 142 1.7× 76 1.5× 20 0.4× 43 272
Chih‐Hsiung Kang Taiwan 9 113 0.5× 47 0.4× 286 3.5× 81 1.6× 20 0.4× 17 377
Simone Scuderi Italy 11 411 1.8× 17 0.1× 116 1.4× 73 1.4× 144 2.9× 42 521
Adam D. Toll United States 12 81 0.4× 91 0.8× 118 1.4× 159 3.1× 9 0.2× 26 376
E R Nairn United Kingdom 9 84 0.4× 47 0.4× 55 0.7× 100 2.0× 14 0.3× 10 273
Akash Agarwal India 9 82 0.4× 53 0.4× 175 2.1× 118 2.3× 31 0.6× 52 349

Countries citing papers authored by Daniel D. Shapiro

Since Specialization
Citations

This map shows the geographic impact of Daniel D. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Shapiro more than expected).

Fields of papers citing papers by Daniel D. Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Shapiro. The network helps show where Daniel D. Shapiro may publish in the future.

Co-authorship network of co-authors of Daniel D. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Shapiro. A scholar is included among the top collaborators of Daniel D. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Shapiro. Daniel D. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paolucci, Iwan, Bruno C. Odisio, Kristy K. Brock, et al.. (2025). Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach. The Oncologist. 30(2).
2.
Das, Arighno, Michael Risk, Daniel D. Shapiro, et al.. (2023). Shorter Ureters Lead to Fewer Strictures Following Cystectomy and Urinary Diversion. Urology. 184. 272–277. 1 indexed citations
3.
Karam, José A., Viraj A. Master, Philippe E. Spiess, et al.. (2023). Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients. Urology. 182. 168–174. 2 indexed citations
4.
Abel, E. Jason, Viraj A. Master, Philippe E. Spiess, et al.. (2023). The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. European Urology Oncology. 7(2). 266–274. 16 indexed citations
5.
Shapiro, Daniel D., José A. Karam, Logan Zemp, et al.. (2023). Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. European Urology Open Science. 50. 43–46. 18 indexed citations
6.
Das, Arighno, Daniel D. Shapiro, Juliana Craig, & E. Jason Abel. (2023). Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC. Nature Reviews Urology. 20(11). 654–668. 9 indexed citations
7.
Borza, Tudor, Jinn‐Ing Liou, Daniel D. Shapiro, et al.. (2023). Impact of Agent Orange Exposure on Non-muscle Invasive Bladder Cancer Outcomes. Urology. 182. 175–180.
8.
Ghasemzadeh, Ali, Brendan Dolan, Juliana Craig, et al.. (2023). Management of stage 1 renal cell cancer in patients immunosuppressed for organ transplantation or autoimmune disease. SHILAP Revista de lepidopterología. 3. 1324696–1324696. 1 indexed citations
9.
Lubner, Meghan G., David Smith, Lu Mao, et al.. (2022). Differentiation of benign from malignant solid renal lesions with MRI-based radiomics and machine learning. Abdominal Radiology. 47(8). 2896–2904. 13 indexed citations
10.
Shapiro, Daniel D., Marı́a Virumbrales-Muñoz, David J. Beebe, & E. Jason Abel. (2022). Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics. Frontiers in Oncology. 12. 871252–871252. 16 indexed citations
11.
Ranasinghe, Weranja, Daniel D. Shapiro, Miao Zhang, et al.. (2021). Optimizing the diagnosis and management of ductal prostate cancer. Nature Reviews Urology. 18(6). 337–358. 22 indexed citations
12.
Pieretti, Alberto, Mary E. Westerman, Niki M. Zacharias, et al.. (2021). Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 39(11). 790.e17–790.e23. 5 indexed citations
13.
Ranasinghe, Weranja, Daniel D. Shapiro, Hyunsoo Hwang, et al.. (2020). Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies. European Urology. 79(2). 298–306. 29 indexed citations
14.
Shapiro, Daniel D. & Pavlos Msaouel. (2020). Causal Diagram Techniques for Urologic Oncology Research. Clinical Genitourinary Cancer. 19(3). 271.e1–271.e7. 37 indexed citations
15.
Westerman, Mary E., Daniel D. Shapiro, Christopher G. Wood, & José A. Karam. (2020). Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma. Urologic Clinics of North America. 47(3). 329–343. 12 indexed citations
16.
Shapiro, Daniel D., Shane A. Wells, Sara L. Best, et al.. (2019). Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery. Urology. 135. 88–94. 35 indexed citations
17.
Shapiro, Daniel D. & E. Jason Abel. (2019). Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitors. Current Opinion in Urology. 29(5). 513–520. 7 indexed citations
18.
Shapiro, Daniel D., David C. Goodspeed, & Wade Bushman. (2018). Urosymphyseal Fistulas Resulting From Endoscopic Treatment of Radiation-induced Posterior Urethral Strictures. Urology. 114. 207–211. 17 indexed citations
19.
20.
Shapiro, Daniel D., Miriam Harel, Fernando Ferrer, & Patrick H. McKenna. (2016). Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma. International Urology and Nephrology. 48(7). 1009–1013. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Martín de Vidales Breakdown of academic impact, for papers by Itay Sternberg Breakdown of academic impact, for papers by Yue Du Breakdown of academic impact, for papers by Roberto Contieri Breakdown of academic impact, for papers by Ikko Tomisaki Breakdown of academic impact, for papers by Chih‐Hsiung Kang Breakdown of academic impact, for papers by Simone Scuderi Breakdown of academic impact, for papers by Adam D. Toll Breakdown of academic impact, for papers by E R Nairn Breakdown of academic impact, for papers by Akash Agarwal
Rankless by CCL
2026